Biosion, Inc.
5th Floor, Building D, 3-1 Zhongdan Unit, South Longshan Rd, Jiangbei New District, Nanjing, Jiangsu, China 210061
TEL: 86-25-5829-1977
Email: sales@biosion.com

NEWS CENTER

 

Biosion and ZhenGe Biotech Sign Global Strategic Partnership Agreement Accelerating Biosion’s Innovative Antibody Pipeline for IND Filing

Biosion and ZhenGe Biotech Sign Global Strategic Partnership Agreement Accelerating Biosion’s Innovative Antibody Pipeline for IND Filing

2020-04-11 13:01
NEWARK, Delaware, USA and NANJING, China, April 9,2020– Biosion Inc. and Shanghai ZhenGe Biotechnology Co. Ltd. jointly announced today that the two parties have signed a global strategic partnership
Biosion, Inc. Appoints Hugh Davis, Ph.D., Chief Operating Officer and President of Biosion USA, Inc.

Biosion, Inc. Appoints Hugh Davis, Ph.D., Chief Operating Officer and President of Biosion USA, Inc.

2020-03-23 13:54
Biosion,Inc.AppointsHughDavis,Ph.D.,ChiefOperatingOfficerandPresidentofBiosionUSA,Inc.NEWARK,Delaware,andNANJING,China. March23,2020–BiosionInc.,announcedtheappointmentofHughM.Davis,Ph.D.,asChiefOpera
Biosynergics, Inc. Completes Series A Financing and Company Restructuring

Biosynergics, Inc. Completes Series A Financing and Company Restructuring

2018-03-16 14:39
On October 29, 2017, Biosynergics, Inc. ("Biosynergics"), a China-based startup biotech company, announced that it has completed a 30 million RMB Series A financing.